These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24550552)

  • 1. Future of implantable devices for cardiac rhythm management.
    Lau CP; Siu CW; Tse HF
    Circulation; 2014 Feb; 129(7):811-22. PubMed ID: 24550552
    [No Abstract]   [Full Text] [Related]  

  • 2. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.
    Sweeney MO
    Circulation; 2012 Jul; 126(3):369-77. PubMed ID: 22801654
    [No Abstract]   [Full Text] [Related]  

  • 3. New frontiers in cardiac devices.
    Dennis AS; Behar JM
    Br J Hosp Med (Lond); 2020 Oct; 81(10):92-103. PubMed ID: 33135932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
    Steffen MM; Osborn JS; Cutler MJ
    Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The progress of electrical treatment of arrhythmia].
    Fang ZX
    Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Jan; 26(1):3-6. PubMed ID: 16104147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.
    Poole JE
    Circulation; 2014 Jan; 129(3):383-94. PubMed ID: 24446408
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation.
    Lüthje L; Vollmann D; Seegers J; Sohns C; Hasenfuss G; Zabel M
    Europace; 2010 Nov; 12(11):1574-80. PubMed ID: 20810533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies of internal defibrillation.
    Dosdall DJ; Ideker RE
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey.
    Todd D; Hernandez-Madrid A; Proclemer A; Bongiorni MG; Estner H; Blomström-Lundqvist C;
    Europace; 2015 Sep; 17(9):1449-53. PubMed ID: 26443791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
    Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
    [No Abstract]   [Full Text] [Related]  

  • 12. The Year in Cardiology 2013: arrhythmias.
    Heinz Kuck K; Hindricks G
    Eur Heart J; 2014 Feb; 35(8):485-90. PubMed ID: 24385372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
    Sullivan RM; Olshansky B
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
    [No Abstract]   [Full Text] [Related]  

  • 14. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J; Abdelhadi R
    Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology.
    Eur Heart J; 1992 Oct; 13(10):1304-10. PubMed ID: 1396800
    [No Abstract]   [Full Text] [Related]  

  • 16. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
    van Veldhuisen DJ; Maass AH; Priori SG; Stolt P; van Gelder IC; Dickstein K; Swedberg K
    Eur J Heart Fail; 2009 Dec; 11(12):1143-51. PubMed ID: 19884129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The year in cardiology 2014: arrhythmias and device therapy.
    Heidbuchel H; Hindricks G
    Eur Heart J; 2015 Feb; 36(5):270-8. PubMed ID: 25559132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Device therapy after acute coronary syndrome].
    Przibille O; Himmrich E; Andreas K; Nowak B
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S36-9. PubMed ID: 24446042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.